DECEMBER 20, 2024

Early Biologic Therapy for CD Linked To Higher Transmural Healing Rates

Beginning biologic therapy within 12 months of Crohn’s disease diagnosis leads to higher rates of transmural healing, according to a study conducted in Europe.

These findings provide further support for transmural healing as a valuable therapeutic target in CD, said lead investigator Joana Revés, MD, a resident in the gastroenterology department at Hospital Beatriz Ângelo, in Loures, Portugal.

The retrospective multicenter study included 154 patients who were diagnosed with CD